HomeCompareBIS vs NOBL

BIS vs NOBL: Dividend Comparison 2026

BIS yields 4.76% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BIS wins by $4.4K in total portfolio value
10 years
BIS
BIS
● Live price
4.76%
Share price
$9.11
Annual div
$0.43
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.3K
Annual income
$645.71
Full BIS calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — BIS vs NOBL

📍 BIS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBISNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BIS + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BIS pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIS
Annual income on $10K today (after 15% tax)
$404.66/yr
After 10yr DRIP, annual income (after tax)
$548.85/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, BIS beats the other by $336.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIS + NOBL for your $10,000?

BIS: 50%NOBL: 50%
100% NOBL50/50100% BIS
Portfolio after 10yr
$25.1K
Annual income
$447.75/yr
Blended yield
1.78%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIS buys
0
NOBL buys
0
No recent congressional trades found for BIS or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBISNOBL
Forward yield4.76%2.17%
Annual dividend / share$0.43$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$27.3K$22.9K
Annual income after 10y$645.71$249.78
Total dividends collected$5.6K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BIS vs NOBL ($10,000, DRIP)

YearBIS PortfolioBIS Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$11,176$476.07$10,917$217.08+$259.00BIS
2$12,456$497.25$11,903$221.48+$553.00BIS
3$13,845$517.93$12,962$225.68+$883.00BIS
4$15,353$538.05$14,099$229.68+$1.3KBIS
5$16,985$557.59$15,319$233.49+$1.7KBIS
6$18,750$576.52$16,628$237.10+$2.1KBIS
7$20,658$594.81$18,033$240.53+$2.6KBIS
8$22,716$612.44$19,539$243.78+$3.2KBIS
9$24,936$629.41$21,154$246.86+$3.8KBIS
10$27,327$645.71$22,884$249.78+$4.4KBIS

BIS vs NOBL: Complete Analysis 2026

BISStock

ProShares UltraShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index.

Full BIS Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this BIS vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIS vs SCHDBIS vs JEPIBIS vs OBIS vs KOBIS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.